127 related articles for article (PubMed ID: 19472399)
1. Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake.
Kidd EA; Spencer CR; Huettner PC; Siegel BA; Dehdashti F; Rader JS; Grigsby PW
Cancer; 2009 Aug; 115(15):3548-54. PubMed ID: 19472399
[TBL] [Abstract][Full Text] [Related]
2. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.
Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
Cancer; 2007 Oct; 110(8):1738-44. PubMed ID: 17786947
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.
Onal C; Reyhan M; Parlak C; Guler OC; Oymak E
Int J Gynecol Cancer; 2013 Jul; 23(6):1104-10. PubMed ID: 23792605
[TBL] [Abstract][Full Text] [Related]
4. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma.
Vural GU; Akkas BE; Demirel BB
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):268-73. PubMed ID: 25018135
[TBL] [Abstract][Full Text] [Related]
5. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
Zhao SJ; Wu N; Zheng R; Liu Y; Zhang WJ; Liang Y; Zhang H; Li XM
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097
[TBL] [Abstract][Full Text] [Related]
6. Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma.
Xu W; Yu S; Ma Y; Liu C; Xin J
Nucl Med Commun; 2017 Mar; 38(3):259-265. PubMed ID: 28118260
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer.
Showalter TN; Miller TR; Huettner P; Rader J; Grigsby PW
Int J Gynecol Cancer; 2009 Nov; 19(8):1412-4. PubMed ID: 20009899
[TBL] [Abstract][Full Text] [Related]
8. Changes in cervical cancer FDG uptake during chemoradiation and association with response.
Kidd EA; Thomas M; Siegel BA; Dehdashti F; Grigsby PW
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):116-22. PubMed ID: 22520475
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
11. 18-fluoro-deoxy-glucose positron emission tomography with computed tomography-based gross tumor volume estimation and validation with magnetic resonance imaging for locally advanced cervical cancers.
Upasani MN; Mahantshetty UM; Rangarajan V; Purandare N; Merchant N; Thakur M; Engineer R; Chopra S; Shrivastava SK
Int J Gynecol Cancer; 2012 Jul; 22(6):1031-6. PubMed ID: 22622949
[TBL] [Abstract][Full Text] [Related]
12. [Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].
Hu YY; Sun XR; Lin XP; Liang PY; Zhang X; Fan W
Ai Zheng; 2009 Sep; 28(9):994-9. PubMed ID: 19728921
[TBL] [Abstract][Full Text] [Related]
13. 11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
Nomori H; Shibata H; Uno K; Iyama K; Honda Y; Nakashima R; Sakaguchi K; Goya T; Takanami I; Koizumi K; Suzuki T; Kaji M; Horio H
J Thorac Oncol; 2008 Dec; 3(12):1427-32. PubMed ID: 19057268
[TBL] [Abstract][Full Text] [Related]
14. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of FDG uptake in early stage non-small cell lung cancer.
Hanin FX; Lonneux M; Cornet J; Noirhomme P; Coulon C; Distexhe J; Poncelet AJ
Eur J Cardiothorac Surg; 2008 May; 33(5):819-23. PubMed ID: 18374589
[TBL] [Abstract][Full Text] [Related]
16. High standardized uptake values of
Yang Z; Wu JR; Wei LL; Liao GX; Yang CJ; Jin GQ; Xiao GY; Su DK
Hell J Nucl Med; 2019; 22(2):96-102. PubMed ID: 31273350
[TBL] [Abstract][Full Text] [Related]
17. Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer.
Surov A; Meyer HJ; Schob S; Höhn AK; Bremicker K; Exner M; Stumpp P; Purz S
Oncotarget; 2017 Apr; 8(17):28285-28296. PubMed ID: 28423698
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
Tsai CS; Lai CH; Chang TC; Yen TC; Ng KK; Hsueh S; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):477-84. PubMed ID: 19464824
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral metabolic heterogeneity of cervical cancer.
Kidd EA; Grigsby PW
Clin Cancer Res; 2008 Aug; 14(16):5236-41. PubMed ID: 18698042
[TBL] [Abstract][Full Text] [Related]
20. (18)F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma.
Chou HH; Chang HP; Lai CH; Ng KK; Hsueh S; Wu TI; Chen MY; Yen TC; Hong JH; Chang TC
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):728-35. PubMed ID: 20069296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
